RBGLY
Reckitt Benckiser Group plc
OTC Markets OTCQXUSDEQUITY
Consumer Defensive
DELAYED
Neutral
-7/100
Last price
13.61
▲ 0.31 (2.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
13.30
Prev close
13.30
Day high
13.65
Day low
13.52
Volume
73.24K
Market cap
$43.13B
P/E (TTM)
11.16
52W range
12.02 – 17.80
Day trading desk
Gap from prior close
-0.00%
Prior close 13.30
VWAP
13.56
+0.34% from price
Relative volume
0.15×
Quiet session
Session range
2.63%
13.30 – 13.65
Position in range
89%
Near session high
ATR (14D)
0.25
1.85% of price
Prior day high
13.35
PDH
Prior day low
13.15
PDL
Bid / ask spread
—
Quote not published
Session volume
73.24K
Avg 490.08K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.18%
+0.3%
1M
-1.31%
-2.8%
3M
+1.04%
-2.4%
6M
-6.07%
-21.0%
YTD
-19.53%
-33.5%
1Y
-14.53%
-30.3%
3Y
-5.56%
-87.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RBGLY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$43.13B
Enterprise value$52.63B
Revenue (TTM)$13.64B
Gross profit$8.12B
EBITDA$3.59B
Net income$2.89B
EPS (TTM)$1.22
Free cash flow$3.09B
Total cash$878.00M
Total debt$10.25B
Book value / share$2.41
Shares outstanding3.17B
Float3.15B
Short % of float—
Dividend yield4.24%
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E11.16
Forward P/E14.52
PEG ratio2.12
Price / sales—
Price / book5.65
EV / revenue3.86
EV / EBITDA14.66
Gross margin59.57%
Operating margin18.19%
Profit margin21.09%
Return on equity48.02%
Return on assets7.88%
Debt / equity179.74
Current ratio0.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $14.21B | $14.17B | $14.61B | $14.45B | +0.3% |
| Operating revenue | $14.21B | $14.17B | $14.61B | $14.45B | +0.3% |
| Cost of revenue | $5.57B | $5.57B | $5.85B | $6.09B | -0.1% |
| Gross profit | $8.63B | $8.60B | $8.76B | $8.36B | +0.5% |
| Research & development | $316.00M | $325.00M | $337.00M | $325.00M | -2.8% |
| Selling, general & admin | $4.89B | $4.83B | $5.08B | $4.64B | +1.3% |
| Total operating expense | $5.21B | $5.16B | $5.41B | $4.95B | +1.0% |
| Operating income | $3.43B | $3.44B | $3.35B | $3.40B | -0.4% |
| Net interest income | -$379.00M | -$321.00M | -$281.00M | -$206.00M | -18.1% |
| Pre-tax income | $3.84B | $2.10B | $2.40B | $3.07B | +82.4% |
| Tax provision | $635.00M | $672.00M | $753.00M | $711.00M | -5.5% |
| Net income | $3.18B | $1.43B | $1.64B | $2.33B | +123.1% |
| Net income to common | $3.18B | $1.43B | $1.64B | $2.33B | +123.1% |
| Basic EPS | 0.98 | 0.42 | 0.48 | 0.68 | +130.0% |
| Diluted EPS | 0.97 | 0.42 | 0.48 | 0.68 | +129.9% |
| EBIT | $4.26B | $2.50B | $2.71B | $3.30B | +70.6% |
| EBITDA | $4.76B | $2.96B | $3.18B | $3.90B | +60.9% |
| Basic shares | 3.26B | 3.36B | 3.44B | 3.43B | -3.0% |
| Diluted shares | 3.27B | 3.37B | 3.45B | 3.44B | -2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.77B | $760.00M | $1.16B | $881.00M | +132.9% |
| Cash & short-term investments | $1.77B | $760.00M | $1.16B | $881.00M | +132.9% |
| Accounts receivable | $1.56B | $1.75B | $1.71B | $1.72B | -11.0% |
| Inventory | $1.47B | $1.52B | $1.64B | $1.82B | -2.9% |
| Total current assets | $5.63B | $4.60B | $5.30B | $5.29B | +22.6% |
| Property, plant & equipment | $2.51B | $2.38B | $2.40B | $2.47B | +5.2% |
| Goodwill & intangibles | $15.81B | $17.57B | $18.59B | $20.20B | -10.0% |
| Total assets | $25.07B | $25.30B | $27.14B | $28.74B | -0.9% |
| Total current liabilities | $6.65B | $7.94B | $8.34B | $8.34B | -16.3% |
| Current debt | $745.00M | $1.34B | $1.60B | $1.64B | -44.6% |
| Long-term debt | $7.41B | $7.01B | $6.61B | $6.85B | +5.7% |
| Total debt | $8.43B | $8.66B | $8.54B | $8.88B | -2.6% |
| Total liabilities | $17.29B | $18.58B | $18.67B | $19.26B | -6.9% |
| Retained earnings | $23.40B | $21.99B | $23.41B | $23.64B | +6.4% |
| Shareholder equity | $7.75B | $6.70B | $8.45B | $9.44B | +15.6% |
| Working capital | -$1.01B | -$3.35B | -$3.04B | -$3.06B | +69.7% |
| Net tangible assets | -$8.06B | -$10.87B | -$10.14B | -$10.76B | +25.8% |
| Shares issued | 674.01M | 707.07M | 707.07M | 727.01M | -4.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $3.84B | $2.10B | $2.40B | $3.07B | +82.4% |
| Depreciation & amortisation | $499.00M | $461.00M | $470.00M | $604.00M | +8.2% |
| Stock-based compensation | $101.00M | $85.00M | $102.00M | $78.00M | +18.8% |
| Change in working capital | -$328.00M | -$146.00M | -$60.00M | -$422.00M | -124.7% |
| Operating cash flow | $2.30B | $2.68B | $2.64B | $2.40B | -14.4% |
| Capital expenditure | -$615.00M | -$465.00M | -$449.00M | -$443.00M | -32.3% |
| Investing cash flow | $1.20B | -$396.00M | -$466.00M | -$139.00M | +401.8% |
| Share buybacks | -$879.00M | -$1.33B | -$207.00M | $0 | +33.8% |
| Dividends paid | -$1.40B | -$1.38B | -$1.34B | -$1.25B | -1.6% |
| Financing cash flow | -$2.43B | -$2.71B | -$1.81B | -$2.38B | +10.4% |
| Free cash flow | $1.68B | $2.22B | $2.19B | $1.95B | -24.1% |
| End cash position | $1.95B | $879.00M | $1.38B | $1.16B | +122.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | YoY |
|---|---|---|---|
| Cash & equivalents | $1.77B | — | — |
| Cash & short-term investments | $1.77B | — | — |
| Accounts receivable | $1.56B | $2.13B | -26.9% |
| Inventory | $1.47B | $1.62B | -9.0% |
| Total current assets | $5.63B | — | — |
| Property, plant & equipment | $2.51B | $2.30B | +8.9% |
| Goodwill & intangibles | $15.81B | $16.71B | -5.4% |
| Total assets | $25.07B | — | — |
| Total current liabilities | $6.65B | — | — |
| Current debt | $745.00M | $2.83B | -73.7% |
| Long-term debt | $7.41B | $6.19B | +19.7% |
| Total debt | $8.43B | $9.29B | -9.2% |
| Total liabilities | $17.29B | — | — |
| Retained earnings | $23.40B | — | — |
| Shareholder equity | $7.75B | $6.31B | +22.7% |
| Working capital | -$1.01B | -$3.89B | +73.9% |
| Net tangible assets | -$8.06B | -$10.40B | +22.5% |
| Shares issued | 674.01M | 707.07M | -4.7% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $3.39B | -6.2% |
| Next quarter | — | — | $3.40B | — |
| Current year | 0.67 | 2 | $13.07B | -8.0% |
| Next year | 0.71 | 2 | $13.46B | +2.9% |
Analyst targets & ownership
Mean target$16.14
High target$18.59
Low target$14.32
Implied upside18.57%
Analyst count4
ConsensusBUY
Strong buy / Buy1 / 1
Hold2
Sell / Strong sell0 / 0
Held by insiders0.00%
Held by institutions0.15%
Institutions holding32
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
13.21
+3.07% from price
SMA 20
13.40
+1.60% from price
SMA 50
13.82
-1.49% from price
SMA 100
13.39
+1.65% from price
SMA 200
14.39
-5.40% from price
EMA 12
13.32
+2.21% from price
EMA 26
13.46
+1.10% from price
EMA 50
13.56
+0.34% from price
RSI (14)
53.2
Neutral
MACD (12,26,9)
-0.15
Hist 0.03
ATR (14)
0.25
1.85% of price
Realised vol 30D
24.1%
Annualised
Bollinger upper
13.93
20, 2σ
Bollinger lower
12.86
20, 2σ
50 / 200 cross
Death
13.82 vs 14.39
Trend bias
Below 200
-5.40%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.13
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
24.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.8%
Peak to trough
Max drawdown 5Y
-41.9%
Peak to trough
ATR 14
0.25
1.85% of price
Beta (reported)
0.28
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 6, 21 | Bernstein | DOWNGRADE | Market Perform | Underperform |
| Feb 25, 21 | Jefferies | UPGRADE | Underperform | Hold |
Dividends & splits
Forward rate$0.58 / yr
Forward yield4.24%
5-year avg yield3.47%
Payout ratio48.74%
Ex-dividend dateAug 10, 2026
Next pay dateSep 28, 2026
Last split959:1000
Split dateFeb 2, 2026
Headlines
Goldman upgrades Reckitt as emerging markets, new products drive growth
Investing.com · 21h ago
Reckitt faces mixed broker forecasts ahead of third-quarter update
Proactive · 7d ago
Global Sanitizer Aerosol Spray Market Forecast, 2026–2032 - Routine Hygiene, Sustainable Packaging and AI Innovation Drive 8.54% CAGR Toward USD 4.12 Billion, with 3M, Ecolab, Reckitt and Clorox Profiled
GlobeNewswire · 15d ago
Manufacturing output down in August; investments by Reckitt, Hitachi
Manufacturing Dive · 20d ago
Stocks to Watch Wednesday Recap: Coinbase, Strategy, Intel, Fraser Group
The Wall Street Journal · 21d ago
Lysol and Mucinex Maker Reckitt Expands U.S. Manufacturing
The Wall Street Journal · 22d ago
RECKITT INVESTS UP TO $600 MILLION TO ACCELERATE U.S.-BASED INNOVATION, EXPAND ACCESS TO HEALTHCARE PRODUCTS, AND STRENGTHEN SUPPLY RESILIENCE
PR Newswire · 22d ago
Mucinex Maker Bets $400 Million More on U.S. Supply Chain
The Wall Street Journal · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.